The Affordable Care Act (ACA) implemented many measures at the beginning of 2014. Amid these changes, stocks responded accordingly.
Here are the best performers among leading U.S. health care stocks since January 2014:
Akorn, Inc. (NASDAQ: AKRX)
Edwards Lifesciences Corp (NYSE: EW)
Intercept Pharmaceuticals Inc (NASDAQ: ICPT)
Illumina, Inc. (NASDAQ: ILMN)
Puma Biotechnology Inc (NYSE: PBYI)
The fate of the ACA is something of a question mark if Republicans take control of the U.S. Senate in the midterm elections, as they are expected to do.
Yet, by and large, the share prices of these five featured stocks have been on the rise in the weeks leading up to the elections.
Here's a brief look at how these five stocks have fared and what analysts expect from them.
Akorn
This drug manufacturer is expected to report strong growth on the top and bottom lines in this week's quarterly report. It has a market capitalization of more than $4 billion and its long-term earnings per share (EPS) growth forecast is about 25 percent.
Note, though, that short interest is about 14 percent of float.
All but two of the 11 analysts surveyed by Thomson/First Call recommend buying shares, with three of them rating the ...
More...